H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.
|Intact Vascular||9/2012||Series A||$15.5M||2|
|NeuWave Medical||9/2012||Series B||$14M||2|